Pathobiology of Diabetic Gastroenteropathy
Pathobiology of Diabetic Gastroenteropathy
批准号:
6848503
负责人:
GIANRICO FARRUGIA
金额:
$32.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2009-06-30
关键词:
biological signal transductioncarbon monoxidecell deathcytoprotectiondiabetes mellitusdiabetic neuropathyelectrophysiologyenteric nervous systemenzyme activityenzyme induction /repressionenzyme mechanismfree radical oxygengastrointestinal motility /pressureheme oxygenasehuman tissueimmunocytochemistryintestine disorderlaboratory mousemolecular biologynitric oxidenitric oxide synthaseoxidative stresspathologic processstomach disordertissue /cell culture
中文摘要
正常的胃肠运动需要肠神经和Cajal间质细胞网络的维持。本提案的总体目标是确定糖尿病性胃肠病(DGE)病理生物学基础的机制。我们的初步数据表明,神经元一氧化氮合酶/一氧化氮(nNOS/NO)和血红素加氧酶/一氧化碳(HO/CO)通路在糖尿病ICC网络的维持中起着核心作用。我们的主要初步观察结果如下:HO1在糖尿病中表达上调,并对糖尿病诱导的氧化应激具有保护作用。NO上调HO1。nNOS的缺失是DGE发展的早期阶段,导致NO减少,HO1上调缺失,随后ICC数量减少。
英文摘要
Normal gastrointestinal motility requires maintenance of enteric nerves and the networks of interstitial cells of Cajal (ICC). The overall objective of this proposal is to identify the mechanisms that underlie the pathobiology of diabetic gastroenteropathy (DGE). Our preliminary data suggest a central role for the neuronal nitric oxide synthase/nitric oxide (nNOS/NO) and the heme oxygenase/carbon monoxide (HO/CO) pathways in the maintenance of ICC networks in diabetes. We have made the following key preliminary observations: HO1 is up-regulated in diabetes and serves as a protective mechanism against diabetes-induced oxidative stress. NO up-regulates HO1. Loss of nNOS is an early step in the development of DGE resulting in decrease in NO, loss of up-regulation of HO1 and subsequent decrease in ICC numbers.
Supporting the hypothesis that NO is cytoprotective to ICC are preliminary data that show that ICC numbers are decreased in nNOS knockout mice, NOS inhibitors decrease ICC numbers, and NO donors increase ICC numbers in culture. Also, nNOS expression is decreased, HO1 up-regulation is lost and ICC numbers are decreased in patients with DGE. We have also developed animal and human tissue models for DGE and developed a non-invasive test to determine gastric emptying in mice. Based on this work we have generated the novel hypothesis that up-regulation of the HO1/CO pathway by reactive oxygen species serves as an initial cytoprotective mechanism against damage to ICC by AGE and reactive oxygen species.
Loss of nNOS expression from enteric nerves leads to loss of continued up-regulation of HO1
resulting in oxidative injury to ICC. Loss of ICC results in loss of the pacemaker signal, failure to
amplify neuronal signals and dysmotility. The proposal has two specific aims. In the first aim we will test the hypothesis that DGE results from initial loss of nNOS expression and subsequent loss of ICC. In the second aim we will test the hypothesis that the HO/CO pathway is cytoprotective to ICC and that aberrant regulation of the HO/CO pathway results in decreased ICC and subsequent DGE. The studies will employ newly developed gastric emptying and ICC culture techniques, electrophysiology, immunohistochemistry, and molecular biology to answer the questions raised. We are now uniquely poised to provide new information on the mechanisms that underlie the development of DGE. As this work will identify basic mechanisms that underlie maintenance of ICC it also has implications for further understanding the pathophysioIogy of many of the motility disorders linked to disorders in ICC number and function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathophysiology of Diabetic Gastroparesis
-
批准号:10403596
-
项目类别:
-
资助金额:$55.3万
-
财政年份:2021
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Pathophysiology of Diabetic Gastroparesis
-
批准号:10618295
-
项目类别:
-
资助金额:$55.41万
-
财政年份:2021
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Pathobiology of Diabetic Gastroenteropathy
-
批准号:7456509
-
项目类别:
-
资助金额:$26.92万
-
财政年份:2007
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Pathobiology of the Enteric System
-
批准号:8685957
-
项目类别:
-
资助金额:$145.75万
-
财政年份:2004
-
负责人:GIANRICO FARRUGIA
-
依托单位:
CALCIUM DYNAMICS IN INTERSTITIAL CELLS OF CAJAL
-
批准号:6381720
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Calcium Dynamics in Interstitial Cells of Cajal
-
批准号:8290442
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
CALCIUM DYNAMICS IN INTERSTITIAL CELLS OF CAJAL
-
批准号:6727510
-
项目类别:
-
资助金额:$21.51万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Calcium Dynamics in Interstitial Cells of Cajal
-
批准号:10425251
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Calcium Dynamics in Interstitial Cells of Cajal
-
批准号:7643917
-
项目类别:
-
资助金额:$24.92万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Calcium Dynamics in Interstitial Cells of Cajal
-
批准号:8063209
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Calcium Dynamics in Interstitial Cells of Cajal
-
批准号:7120528
-
项目类别:
-
资助金额:$26.19万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Calcium Dynamics in Interstitial Cells of Cajal
-
批准号:8497450
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
CALCIUM DYNAMICS IN INTERSTITIAL CELLS OF CAJAL
-
批准号:6517709
-
项目类别:
-
资助金额:$20.28万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
CALCIUM DYNAMICS IN INTERSTITIAL CELLS OF CAJAL
-
批准号:6635229
-
项目类别:
-
资助金额:$20.89万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Calcium Dynamics in Interstitial Cells of Cajal
-
批准号:6965504
-
项目类别:
-
资助金额:$26.82万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Calcium Dynamics in Interstitial Cells of Cajal
-
批准号:7257156
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Calcium Dynamics in Interstitial Cells of Cajal
-
批准号:7450791
-
项目类别:
-
资助金额:$24.92万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
Calcium Dynamics in Interstitial Cells of Cajal
-
批准号:7882785
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2000
-
负责人:GIANRICO FARRUGIA
-
依托单位:
MECHANOTRANSDUCTION IN INTESTINAL SMOOTH MUSCLE CELLS
-
批准号:6381355
-
项目类别:
-
资助金额:$14.31万
-
财政年份:1997
-
负责人:GIANRICO FARRUGIA
-
依托单位:
MECHANOTRANSDUCTION IN INTESTINAL SMOOTH MUSCLE CELLS
-
批准号:2749621
-
项目类别:
-
资助金额:$14.31万
-
财政年份:1997
-
负责人:GIANRICO FARRUGIA
-
依托单位:
海外基金